Skip to content
FDA

Mai Tai 20mg Gummies Brand Name: None - unlabeled bulk (private-label consignee) Generic Name: Dietary Supplement Strength: 20mg CBD and 20mg D9 THC per gummy Dosage: Not declared at bulk stage (consignee determines serving size) Form: Gummy Administration: Oral Intended use: Dietary supplement for further packaging/labeling by consignee Type of packaging: Shipped in poly gusset bags, inside corrugated brown boxes, no consumer label applied. Net wt. Mai Tai: 24 bags x 5kg and 1 bag x 4kg UPC: N/A (unlabeled bulk) Firm name & address: None (no consumer label)

Published: Aug 26, 2025
Updated: Nov 4, 2025
Recall #: H-0624-2025
Product Information

Brand

Extract Labs, Inc.

Category

Food

Description

Potential peanut protein cross-contact.

FDA Classification

Class II

May cause temporary health problems or slight threat of serious nature

Status

Terminated

Recall Type

Voluntary: Firm initiated

Affected Lot Codes

Check your product packaging for these codes:

Lot: 25JD042507A EXP: 07/2027 Printed on bulk bag identifier adhesive
What You Should Do

Available Remedies

Dispose of ProductRefund Available

Recommended Actions

  1. 1Stop using the product immediately. Do not continue to use, sell, or distribute the recalled product.
  2. 2Check if you have the recalled product. Verify the brand, model number, lot codes, or UPC listed in the recall.
  3. 3Follow the remedy instructions. Return the product to the place of purchase for a full refund. Dispose of the product safely according to local regulations.
  4. 4Visit the official recall page for complete details, contact information, and deadline information (if applicable).

Official Recall Information

For the most accurate and up-to-date information, including contact details and deadlines, please visit the official recall page from FDA.

View Official Recall Page

Need more help? If you have questions or have experienced issues with this product, you can:

  • Contact the manufacturer or retailer where you purchased the product
  • Report an incident to SaferProducts.gov
  • Consult with the FDA for additional guidance